Karli Hochstatter
Dados Biográficos
| ID | 9013528 |
|---|---|
| NOME | Karli Hochstatter |
| PRENOMES | Karli |
| SOBRENOME | Hochstatter |
| ASSINATURA | HOCHSTATTER K |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2021 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Overdose education and naloxone distribution in jails
BACKGROUND: Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid overdose. Despite evidence of its acceptability and effectiveness at reducing the risk of opioid overdose death after release from incarceration, only an estimated 25% of US jails provide naloxone upon release. This study…
Associations between Cannabis Use and Sexual Risk Behavior among Women under Community Supervision
OBJECTIVES: Cannabis use and sexual risk behavior have been found to co-occur, but more research on these associations is needed among criminal justice-involved women (i.e., courts, jails, or prisons). METHODS: Regression models examined past 90-day cannabis use on unprotected sex, multiple sexual partners, and STIs/HIV among 306 women under NYC community supervision, adjusting for alcohol, other illicit substances, and socio-demographics. RESULT…
Sem obras proeminentes nesta página.
Associations between Cannabis Use and Sexual Risk Behavior among Women under Community Supervision
OBJECTIVES: Cannabis use and sexual risk behavior have been found to co-occur, but more research on these associations is needed among criminal justice-involved women (i.e., courts, jails, or prisons). METHODS: Regression models examined past 90-day cannabis use on unprotected sex, multiple sexual partners, and STIs/HIV among 306 women under NYC community supervision, adjusting for alcohol, other illicit substances, and socio-demographics. RESULT…
Overdose education and naloxone distribution in jails
BACKGROUND: Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid overdose. Despite evidence of its acceptability and effectiveness at reducing the risk of opioid overdose death after release from incarceration, only an estimated 25% of US jails provide naloxone upon release. This study…
Criminology (2 obras) · Medicine (2 obras) · Psychiatry (2 obras) · Psychology (2 obras) · Substance Abuse Treatment and Outcomes (2 obras) · Cannabis (1 obras) · Cannabis and Cannabinoid Research (1 obras) · Clinical Psychology (1 obras) · Criminal justice (1 obras) · Demographics (1 obras)